Source:http://linkedlifedata.com/resource/pubmed/id/19940973
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-23
|
pubmed:abstractText |
Chronic inflammation can be a major risk factor for cancer development and may contribute to the high worldwide incidence of hepatocellular carcinoma (HCC). Cyclooxygenase-2 (COX-2) is known to be an important mediator of inflammatory responses; however, its link to hepatitis B virus (HBV)-mediated inflammatory responses has not been established. Here, we demonstrate that the expression of COX-2 mRNA and protein was significantly elevated in cells transfected by HBV replicon but not in cells transfected by HBV genome lacking the HBx gene. Notably, COX-2 induction was correlated with HBx's ability to increase reactive oxygen species (ROS) levels. Consistently with this, antioxidant treatment and ectopic expression of manganese superoxide dismutase or catalase completely abolished COX-2 induction. Interestingly, a mitochondria localization-defective mutant of HBx (HBx(Delta 68-117)) neither increased intracellular ROS levels nor induced COX-2 expression. HBx(68-117), which encodes only amino acids 68-117 and is sufficient for mitochondria localization, increased ROS levels but did not induce COX-2 expression. Similarly, HBx targeting to the outer membrane of mitochondria (Mito-HBx) increased ROS but also failed to increase COX-2 expression, suggesting that other cytoplasmic signaling pathways are involved in HBx-mediated COX-2 induction. Indeed, inhibition of cytoplasmic calcium signaling by cyclosporine A, blocking mitochondrial permeability transition pore, and herbimycin, and inhibition of calcium-dependent tyrosine kinase suppressed HBV-mediated COX-2 induction. Thus, the data indicate that both mitochondrial ROS and cytoplasmic calcium signaling are necessary for the COX-2 induction. Our studies revealed a pathophysiological link between HBV infection and hepatic inflammation, and this chain of events might contribute to early steps in HBV-associated liver carcinogenesis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1432-1440
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
359-69
|
pubmed:dateRevised |
2011-7-8
|
pubmed:meshHeading |
pubmed-meshheading:19940973-Cell Line,
pubmed-meshheading:19940973-Cell Line, Tumor,
pubmed-meshheading:19940973-Cyclooxygenase 2,
pubmed-meshheading:19940973-Cytoplasm,
pubmed-meshheading:19940973-Flow Cytometry,
pubmed-meshheading:19940973-Hepatitis B virus,
pubmed-meshheading:19940973-Humans,
pubmed-meshheading:19940973-Inflammation,
pubmed-meshheading:19940973-Mitochondria,
pubmed-meshheading:19940973-Plasmids,
pubmed-meshheading:19940973-Reactive Oxygen Species,
pubmed-meshheading:19940973-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:19940973-Signal Transduction,
pubmed-meshheading:19940973-Subcellular Fractions,
pubmed-meshheading:19940973-Trans-Activators
|
pubmed:year |
2010
|
pubmed:articleTitle |
HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression.
|
pubmed:affiliation |
Department of Biochemistry, School of Medicine, Ajou University, Suwon, 443-721, South Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|